ADALIMUMAB

adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices

ADALIMUMAB (13229G)

adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices
13229G
Body System:
Manner of administration:Injection
Private
S100 HSD Private
Authority Required (STREAMLINED)

Restriction  17713

Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 2 # of repeats: 5 DPMQ: $470.82 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Hadlima
Humira
Hyrimoz
Yuflyma